These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17785546)

  • 1. Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative.
    Molinolo AA; Hewitt SM; Amornphimoltham P; Keelawat S; Rangdaeng S; Meneses García A; Raimondi AR; Jufe R; Itoiz M; Gao Y; Saranath D; Kaleebi GS; Yoo GH; Leak L; Myers EM; Shintani S; Wong D; Massey HD; Yeudall WA; Lonardo F; Ensley J; Gutkind JS
    Clin Cancer Res; 2007 Sep; 13(17):4964-73. PubMed ID: 17785546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
    Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
    Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model.
    Czerninski R; Amornphimoltham P; Patel V; Molinolo AA; Gutkind JS
    Cancer Prev Res (Phila); 2009 Jan; 2(1):27-36. PubMed ID: 19139015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01.
    Amornphimoltham P; Sriuranpong V; Patel V; Benavides F; Conti CJ; Sauk J; Sausville EA; Molinolo AA; Gutkind JS
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4029-37. PubMed ID: 15217935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma.
    Georgy SR; Cangkrama M; Srivastava S; Partridge D; Auden A; Dworkin S; McLean CA; Jane SM; Darido C
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26063791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients.
    Clark C; Shah S; Herman-Ferdinandez L; Ekshyyan O; Abreo F; Rong X; McLarty J; Lurie A; Milligan EJ; Nathan CO
    Laryngoscope; 2010 Jun; 120(6):1159-65. PubMed ID: 20513033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies.
    Vander Broek R; Mohan S; Eytan DF; Chen Z; Van Waes C
    Oral Dis; 2015 Oct; 21(7):815-25. PubMed ID: 24219320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck.
    Le Tourneau C; Siu LL
    Curr Opin Oncol; 2008 May; 20(3):256-63. PubMed ID: 18391623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma.
    Horn D; Hess J; Freier K; Hoffmann J; Freudlsperger C
    Expert Opin Ther Targets; 2015 Jun; 19(6):795-805. PubMed ID: 25652792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
    Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Squarize CH; Castilho RM; Sriuranpong V; Pinto DS; Gutkind JS
    Neoplasia; 2006 Sep; 8(9):733-46. PubMed ID: 16984731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma.
    Schneider A; Younis RH; Gutkind JS
    Neoplasia; 2008 Nov; 10(11):1295-302. PubMed ID: 18953439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation.
    Yang MH; Chiang WC; Chou TY; Chang SY; Chen PM; Teng SC; Wu KJ
    Clin Cancer Res; 2006 Jan; 12(2):507-15. PubMed ID: 16428493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases.
    Chaux A; Munari E; Cubilla AL; Hicks J; Lecksell K; Burnett AL; Netto GJ
    Histopathology; 2014 May; 64(6):863-71. PubMed ID: 24279699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
    Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
    Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.
    Nijkamp MM; Hoogsteen IJ; Span PN; Takes RP; Lok J; Rijken PF; van der Kogel AJ; Bussink J; Kaanders JH
    Radiother Oncol; 2011 Oct; 101(1):165-70. PubMed ID: 21775008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
    Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS
    Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma.
    Chen CY; Chiou SH; Huang CY; Jan CI; Lin SC; Hu WY; Chou SH; Liu CJ; Lo JF
    J Pathol; 2009 Nov; 219(3):347-55. PubMed ID: 19681071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.